Sunday, June 16, 2013

• China Biotech In Review: Mindray Medical Buys U.S. Ultrasound Companyat Seeking Alpha (Sun, Jun 16)

Monday, June 10, 2013

• BioLineRx signs out-licensing agreement with CTTQ for hep C drugtheflyonthewall.com (Mon, Jun 10)
• BioLineRx Enters into Collaboration to Develop and Commercialize Hepatitis C Drug with CTTQ, Leading Chinese Pharma Company for Liver Disease TherapeuticsBusiness Wire (Mon, Jun 10)

Friday, June 7, 2013

• BioLineRx Enrolls First Patient in StudyZacks (Fri, Jun 7)

Thursday, June 6, 2013

• BioLineRx Enrolls First Patient in Phase 2 Clinical Trial for BL-8040, for Treatment of LeukemiaBusiness Wire (Thu, Jun 6)

Monday, May 20, 2013

• AbbVie's Latest Drug Deal Marks A Shift In The Celiac Disease Therapeutics Fieldat Seeking Alpha (Mon, May 20)

Friday, May 17, 2013

• BioLineRx Enters into “At-The-Market” Offering Agreement with Stifel, Nicolaus & CompanyBusiness Wire (Fri, May 17)

Thursday, May 9, 2013

• BioLineRx to Present at the Oppenheimer 14th Annual Israeli Conference on May 12thBusiness Wire (Thu, May 9)

Tuesday, May 7, 2013

• BioLineRx Reports First Quarter 2013 ResultsBusiness Wire (Tue, May 7)

Thursday, May 2, 2013

• BioLineRx's BL-7010, for the Treatment of Celiac, to be Presented at Two Leading ConferencesBusiness Wire (Thu, May 2)

Wednesday, May 1, 2013

• BioLineRx Pipeline Returns To The Winner's Circleat Seeking Alpha (Wed, May 1)

Tuesday, April 30, 2013

• BioLineRx to Report First Quarter 2013 Results on May 7, 2013Business Wire (Tue, Apr 30)

Monday, April 29, 2013

• BioLineRx Enrolls First Patient in Phase I/II Clinical Trial for BL-8020, an Oral, Interferon-Free Treatment for Hepatitis CBusiness Wire (Mon, Apr 29)

Thursday, April 18, 2013

• Positive Data on BioLineRx TreatmentZacks (Thu, Apr 18)
• 5 Stocks Under $10 Set to Soarat TheStreet (Thu, Apr 18)
• BioLineRx to Present at the 12th Annual Needham Healthcare Conference in New York on April 30, 2013Business Wire (Thu, Apr 18)

Wednesday, April 17, 2013

• BioLineRx Announces Positive Phase II Results for BL-7040, an Orally Available Treatment for Inflammatory Bowel DiseaseBusiness Wire (Wed, Apr 17)

Tuesday, April 16, 2013

• BioLineRx to Start BL-8040 StudyZacks (Tue, Apr 16)
• Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business DevelopmentPR Newswire (Tue, Apr 16)

Wednesday, April 10, 2013

• BioLineRx receives approval for Phase II clinical trial for leukemia candidatetheflyonthewall.com (Wed, Apr 10)

Add BLRX News to My Yahoo!